Shuji Saeki
About
In The Last Decade
Shuji Saeki
33 papers receiving 446 citations
Peers
Comparison fields: 5 of 89
- Surgery 218
- Biomedical Engineering 104
- Electrical and Electronic Engineering 82
- Molecular Biology 70
- Public Health, Environmental and Occupational Health 70
Countries citing papers authored by Shuji Saeki
This map shows the geographic impact of Shuji Saeki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuji Saeki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuji Saeki more than expected).
Fields of papers citing papers by Shuji Saeki
This network shows the impact of papers produced by Shuji Saeki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuji Saeki. The network helps show where Shuji Saeki may publish in the future.
Co-authorship network of co-authors of Shuji Saeki
This figure shows the co-authorship network connecting the top 25 collaborators of Shuji Saeki. A scholar is included among the top collaborators of Shuji Saeki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuji Saeki. Shuji Saeki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 187 | |
| 2 | 6 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 0 | |
| 8 | 1 | |
| 9 | 0 | |
| 10 | 26 | |
| 11 | 8 | |
| 12 | 6 | |
| 13 | 2 | |
| 14 | 34 | |
| 15 | 33 | |
| 16 | 1 | |
| 17 | A role for plasma membrane potential in doxorubicin--induced cytotoxicity. | 6 |
| 18 | [Combination of a biscoclaurine alkaloid, cepharanthine, and anticancer agents: effects and mechanism in human gastric and pancreatic carcinoma cell lines]. | 3 |
| 19 | 33 | |
| 20 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.